ESSA Pharma Inc. (EPIX)

ESSA Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Year Ending	TTM	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Net Income	-27.73	-26.58	-35.1	-36.81	-23.45	-12.76
Depreciation & Amortization	0.1	0.12	0.12	0.11	0.11	0
Share-Based Compensation	3.94	5.01	7.89	9.48	7.52	1.15
Other Operating Activities	2.27	1.67	-0.91	1.8	-1.17	-0.64
Operating Cash Flow	-21.42	-19.78	-28	-25.42	-16.98	-12.25
Change in Investments	68	-3.53	-53.05	-35.01	-21.74	0.2
Investing Cash Flow	68	-3.53	-53.05	-35.01	-21.74	0.2
Share Issuance / Repurchase	0.86	0.07	0.39	151.32	49.07	36
Debt Issued / Paid	-0.07	-0.14	-0.13	-0.1	-4.04	-3.21
Other Financing Activities	-	-	-	-9.23	-3.26	17.77
Financing Cash Flow	0.79	-0.07	0.25	141.99	41.78	50.56
Exchange Rate Effect	0	0	0.05	-0.06	-0.06	-0.02
Net Cash Flow	47.38	-23.37	-80.75	81.5	3	38.49
Free Cash Flow	-21.42	-19.78	-28	-25.42	-16.98	-12.25
Free Cash Flow Per Share	-0.48	-0.45	-0.64	-0.66	-0.76	-1.45

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).